Insights from 2023 ESMO Asia Annual Meeting


 

ESMO Asia 2023 Insights: "AEs as Potential Predictive Factors of Activity in Patients With Advanced HCC Treated With Atezolizumab + Bevacizumab"

41 views
January 17, 2024
Comments 0
Login to view comments. Click here to Login